Recurrent Adult Acute Myeloid Leukemia
Oncology
1
Pipeline Programs
2
Companies
2
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
HM
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
2027
Bio-Path HoldingsBP1001
Huadong MedicineCMGV
Clinical Trials (2)
Clinical Trial of BP1001 (L-Grb-2 Antisense Oligonucleotide) in CML, AML, ALL & MDS
Start: Jun 2010Est. completion: Mar 2017
Phase 1Completed
A Prospective, Multicenter, and Exploratory Study of CMGV in the Treatment of Recurrent Adult AML and MDS-EB-2/Elder AML
Start: Feb 2024Est. completion: Dec 2027
N/ARecruiting
Related Jobs in Oncology
Senior Research Associate, Immuno-Oncology
SystImmune
6m ago
$60K - $85K/yr
Research Associate I/II, Immuno-Oncology
SystImmune
6m ago
Office Administrator
SystImmune
7m ago
$60K - $80K/yr
Scientist/Sr Scientist
TwoStep Therapeutics
San Carlos
17m ago
Working Student Office Management Support (m/f/d)
Mindpeak
Hamburg
21m ago
Senior Medical Project Manager (m/f/d)
Mindpeak
Hamburg
21m ago
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials
2 companies competing in this space